Merck KGaA | Income Statement
Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
11,095
11,363
12,845
15,024
15,327
14,836
Cost of Goods Sold (COGS) incl. D&A
3,806
4,363
4,920
6,336
6,411
6,428
Gross Income
7,289
7,000
7,925
8,688
8,916
8,408
SG&A Expense
5,050
5,178
5,783
6,313
6,692
6,602
EBIT
2,091
-
2,115
-
2,211
1,753
Unusual Expense
575
191
435
436
340
277
Non Operating Income/Expense
19
50
66
480
610
184
Interest Expense
177
160
292
277
283
254
Pretax Income
1,389
1,557
1,487
2,154
2,224
1,461
Income Tax
180
392
368
521
386
368
Consolidated Net Income
1,209
1,165
1,119
1,633
2,610
1,093
Net Income
1,202
1,157
1,109
1,629
2,600
1,093
Net Income After Extraordinaries
1,202
1,157
1,104
1,629
2,600
1,188
Net Income Available to Common
1,202
1,157
1,115
1,629
2,600
390
EPS (Basic)
2.77
2.66
2.56
3.75
5.98
7.76
Basic Shares Outstanding
435
435
435
435
435
435
EPS (Diluted)
2.77
2.66
2.56
3.75
5.98
7.76
Diluted Shares Outstanding
435
435
435
435
435
435
EBITDA
3,329
3,087
3,498
4,173
3,970
3,501
Other Operating Expense
148
3
27
8
13
53
Non-Operating Interest Income
30
32
32
20
26
55
Minority Interest Expense
7
8
9
4
10
-
About Merck KGaA
View Profile
